Usefulness of local therapy for distant metastases of differentiated thyroid cancer
European Thyroid Journal · 2025
DOI: 10.1530/etj-24-0237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Thyroid Journal, 2025. Verfasst von Sueyoshi Moritani und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Bone Neoplasms, Brain Neoplasms, Lung Neoplasms. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Treatment for distant metastases (DM) of differentiated thyroid cancer (DTC) aims to improve the prognosis and quality of life (QOL). Radioactive iodine and molecular targeted therapies are the primary systemic treatments for DM. Combining these with local treatments, such as surgery and radiotherapy targeting metastatic sites, may provide additional benefits to systemic therapy.
Methods
This study reviewed the additional effects of local therapies on common metastatic sites of DTC, such as pulmonary or bone metastases (BM), the efficacy of bone-modifying agents (BMAs) for BM, and the therapeutic effects of local treatments for less common brain metastases.
Results
Although based on retrospective studies with no definitive conclusions on the effectiveness of each treatment, local therapy for DM in DTC patients has been shown to enhance prognosis and QOL in several studies. Considering the results of clinical trials for metastatic tumors, local therapy for one or a few pulmonary or BM in DTC should be considered, if expected to improve prognosis and QOL. Surgical intervention is recommended for spinal metastases presenting with spinal compression symptoms or for long BM in extremities at risk of pathological or impending fractures. BMAs are also recommended to reduce the risk of skeletal-related events. Surgery, stereotactic radiotherapy, and whole-brain radiotherapy are suggested for brain metastases to improve the prognosis and QOL.
Conclusion
Incorporating local therapy alongside systemic treatment can enhance the prognosis and QOL and should be considered a viable treatment option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Sueyoshi Moritani
Zitieren
APA
Moritani, S., Takenobu, M., Yasunaga, M., Fujii, T., & Kitano, H. (2025). Usefulness of local therapy for distant metastases of differentiated thyroid cancer. European Thyroid Journal. https://doi.org/10.1530/etj-24-0237
Vancouver
Moritani S, Takenobu M, Yasunaga M, Fujii T, Kitano H. Usefulness of local therapy for distant metastases of differentiated thyroid cancer. European Thyroid Journal. 2025. doi:10.1530/etj-24-0237
BibTeX
@article{Moritani2025,
author = {Moritani, Sueyoshi and Takenobu, Masao and Yasunaga, Masakazu and Fujii, Taihei and Kitano, Hiroya},
title = {Usefulness of local therapy for distant metastases of differentiated thyroid cancer},
journal = {European Thyroid Journal},
year = {2025},
doi = {10.1530/etj-24-0237}
}
EUVIMED